Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dermtech Inc
(NQ:
DMTK
)
0.0940
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Dermtech Inc
< Previous
1
2
3
4
5
6
Next >
DermTech Announces Release Date for Second-Quarter 2022 Financial Results
July 26, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Appoints Two New Board Members
July 18, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Joins PeDRA Corporate Council, Supporting Efforts to Address Pediatric Skin Diseases
July 06, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech to Present on Genomic Innovation in Dermatology at AHIP 2022
June 14, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech to Present at the William Blair Growth Stock Conference
June 01, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Sponsors The Sun Bus to Bring Free Skin Cancer Screenings to More Than 50 Locations Across the U.S.
May 24, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Presents New Research Differentiating Atopic Dermatitis and Psoriasis at the Society for Investigative Dermatology’s Annual Meeting
May 18, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Reinforces Longstanding Mission to Help Reduce Melanoma Deaths, Aligning with the Biden Administration’s Renewed ‘Cancer Moonshot’ Program
May 10, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Kicks Off Second Annual #Stickit2Melanoma Campaign, Raising Awareness for Melanoma and the Importance of Skin Exams
May 04, 2022
From
DermTech
Via
Business Wire
DermTech Reports First-Quarter 2022 Financial Results; Company Affirms Full-Year 2022 Outlook
May 03, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Publication of New GvHD Clinical Research Conducted in Collaboration with Memorial Sloan Kettering Cancer Center
April 28, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Expands Telehealth Application, DermTech Connect, Across 44 States
April 26, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech to Showcase DermTech Stratum, an Expanded Translational Medicine Service Offering, at San Diego’s Inaugural ‘Innovation Day’ Event
April 25, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Release Date for First-Quarter 2022 Financial Results
April 14, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 28, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Management to Present at Upcoming Investor Conferences
February 24, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Welcomes Adelle Walker as Vice President of Consumer Products
February 23, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech to Announce Fourth Quarter and Full-Year Financial Results
February 15, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Management to Participate in Upcoming Investor Conferences
January 31, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Unveils DermTech Stratum, an Expanded Translational Medicine Service Offering for Non-invasive Biomarker Analysis
November 29, 2021
From
DermTech, Inc.
Via
Business Wire
DermTech Presents Precision Approaches to Personalized Dermatology at 2021 Dermatology Drug Development Summit
November 18, 2021
From
DermTech, Inc.
Via
Business Wire
DermTech Reports Third Quarter 2021 Financial Results
November 09, 2021
From
DermTech, Inc.
Via
Business Wire
DermTech and DermatologistOnCall Enter Agreement to Improve Access to the DermTech Melanoma Test with Noninvasive, At-Home Sample Collection
November 08, 2021
From
DermTech, Inc.
Via
Business Wire
DermTech Management to Participate in Upcoming Investor Conferences
November 02, 2021
From
DermTech, Inc.
Via
Business Wire
DermTech to Announce Third Quarter Financial Results on November 9, 2021
October 26, 2021
From
DermTech, Inc.
Via
Business Wire
DermTech Presents in Expert Panel at Inaugural Alliance for Innovation in Integrated Healthcare Summit
October 11, 2021
From
DermTech
Via
Business Wire
DermTech Announces New Appointment of L’Oréal USA Leader Nathalie Gerschtein Keraudy to its Board of Directors
October 04, 2021
From
DermTech, Inc.
Via
Business Wire
DermTech Sponsors San Diego Open; Partners with Tennis Pro Brandon Nakashima to Raise Awareness for Sun Safety
September 27, 2021
From
DermTech, Inc.
Via
Business Wire
DermTech Study, “Non-Invasive Detection of Genomic Atypia Increases Real-World NPV and PPV of the Melanoma Diagnostic Pathway and Reduces Biopsy Burden,” Published in SKIN: The Journal Of Cutaneous Medicine
September 14, 2021
From
DermTech, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.